[1]
|
M. Bax, J. Van Heemst, T. Huizinga and R. Toes, “Genetics of Rheumatoid Arthritis: What Have We Learned?” Immunogenetics, Vol. 63, No. 8, 2011, pp. 459-466.
doi:10.1007/s00251-011-0528-6
|
[2]
|
D. E. De Almeida, S. Ling and J. Holoshitz, “New Insights into the Functional Role of the Rheumatoid Arthritis Shared Epitope,” FEBS Letters, Vol. 585, No. 23, 2011, pp. 3619-3626. doi:10.1016/j.febslet.2011.03.035
|
[3]
|
P. K. Gregersen, J. Silver and R. J. Winchester, “The Shared Epitope Hypothesis. An Approach to Understanding the Molecular Genetics of Susceptibility to Rheumatoid Arthritis,” Arthritis & Rheumatism, Vol. 30, No. 11, 1987, pp. 1205-1213. doi:10.1002/art.1780301102
|
[4]
|
N. Carrier, “The DERAA HLA-DR Alleles in Patients with Early Polyarthritis: Protection against Severe Disease and Lack of Association with Rheumatoid Arthritis Autoantibodies,” Arthritis and rheumatism, Vol. 60, No. 3, 2009, pp. 698-707. doi:10.1002/art.24353
|
[5]
|
S. L. Mackie, J. C. Taylor, S. G. Martin, P. Wordsworth, S. Steer, A. G. Wilson, J. Worthington, P. Emery, J. H. Barrett and A. W. Morgan, “A Spectrum of Susceptibility to Rheumatoid Arthritis within HLA-DRB1: Stratification by Autoantibody Status in a Large UK Population,” Genes Immun, Vol. 13, No. 2, 2012, pp. 120-128.
doi:10.1038/gene.2011.60
|
[6]
|
I. B. McInnes and G. Schett, “The Pathogenesis of Rheumatoid Arthritis,” New England Journal of Medicine, Vol. 365, No. 23, 2011, pp. 2205-2219.
doi:10.1056/NEJMra1004965
|
[7]
|
L. P. Blanco, S. Ling and J. Holoshitz, “Oxidative Stress in Rheumatoid Arthritis: New Insights.,” In: I. Dichi, A. Colado Simao, J. Wander Bregano and R. Cecchini, Eds., Role of Oxidative Stress in Chronic Diseases, Science Publishers, Hampshire, 2013.
|
[8]
|
M. Chabaud, J. M. Durand, N. Buchs, F. Fossiez, G. Page, L. Frappart and P. Miossec, “Human Interleukin-17: A T Cell—Derived Proinflammatory Cytokine Produced by the Rheumatoid Synovium,” Arthritis & Rheumatism, Vol. 42, No. 5, 1999, pp. 963-970.
doi:10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E
|
[9]
|
S. Kotake, N. Udagawa, N. Takahashi, K. Matsuzaki, K. Itoh, S. Ishiyama, S. Saito, K. Inoue, N. Kamatani, M. T. Gillespie, T. J. Martin and T. Suda, “IL-17 in Synovial Fluids from Patients with Rheumatoid Arthritis Is a Potent Stimulator of Osteoclastogenesis,” The Journal of Clinical Investigation, Vol. 103, No. 9, 1999, pp. 1345-1352. doi:10.1172/JCI5703
|
[10]
|
P. Miossec and W. B. Van Den Berg, “IL-17 as a Future Therapeutic Target for Rheumatoid Arthritis,” Nature Reviews Rheumatology, Vol. 5, No. 10, 2009, p. 549-553.
|
[11]
|
M. C. Genovese, F. Van Den Bosch, S. A. Roberson, S. Bojin, I. M. Biagini, P. Ryan and J. Sloan-Lancaster, “LY2439821, a Humanized Anti-Interleukin-17 Monoclonal Antibody, in the Treatment of Patients with Rheumatoid Arthritis: A Phase I Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study,” Arthritis & Rheumatism, Vol. 62, No. 4, 2010, pp. 929-939.
doi:10.1002/art.27334
|
[12]
|
D. E. De Almeida, S. Ling, X. Pi, A. M. Hartmann-Scruggs, P. Pumpens and J. Holoshitz, “Immune Dysregulation by the Rheumatoid Arthritis Shared Epitope,” The Journal of Immunology, Vol. 185, No. 3, 2010, pp. 1927-1934. doi:10.4049/jimmunol.0904002
|
[13]
|
J. Holoshitz, D. E. De Almeida and S. Ling, “A Role for Calreticulin in the Pathogenesis of Rheumatoid Arthritis,” Annals of the New York Academy of Sciences, Vol. 1209, No. 1, 2010, pp. 91-98.
doi:10.1111/j.1749-6632.2010.05745.x
|
[14]
|
J. Holoshitz, Y. Liu, J. Fu, J. Joseph, S. Ling, A. Colletta, P. Sharma, D. Begun, S. Goldstein and R. Taichman, “An HLA-DRB1—Coded Signal Transduction Ligand Facilitates Inflammatory Arthritis: A New Mechanism of Auto-immunity,” The Journal of Immunology, Vol. 190, No. 1, 2012, pp. 48-57. doi:10.4049/jimmunol.1202150
|
[15]
|
S. Ling, A. Lai, O. Borschukova, P. Pumpens and J. Holoshitz, “Activation of Nitric Oxide Signaling by the Rheumatoid Arthritis Shared Epitope,” Arthritis & Rheumatism, Vol. 54, No. 11, 2006, pp. 3423-3432.
doi:10.1002/art.22178
|
[16]
|
S. Ling, A. Cheng, P. Pumpens, M. Michalak and J. Holoshitz, “Identification of the Rheumatoid Arthritis Shared Epitope Binding Site on Calreticulin,” PLoS One, Vol. 5, No. 7, 2010, p. e11703.
doi:10.1371/journal.pone.0011703
|
[17]
|
S. Ling, X. Pi and J. Holoshitz, “The Rheumatoid Arthritis Shared Epitope Triggers Innate Immune Signaling via Cell Surface Calreticulin,” The Journal of Immunology, Vol. 179, No. 9, 2007, pp. 6359-6367.
|
[18]
|
S. Ling, E. N. Cline, T. S. Haug, D. A. Fox and J. Holoshitz, “Citrullinated Calreticulin Potentiates Rheumatoid Arthritis Shared Epitope Signaling,” Arthritis & Rheumatism, Vol. 65, No. 3, 2012, pp. 618-626.
|
[19]
|
F. A. Arosa, O. De Jesus, G. Porto, A. M. Carmo and M. de Sousa, “Calreticulin Is Expressed on the Cell Surface of Activated Human Peripheral Blood T Lymphocytes in Association with Major Histocompatibility Complex Class I Molecules,” Journal of Biological Chemistry, Vol. 274, No. 24, 1999, pp. 16917-16922.
doi:10.1074/jbc.274.24.16917
|
[20]
|
P. P. Banerjee, D. S. Vinay, A. Mathew, M. Raje, V. Parekh, D. V. R. Prasad, A. Kumar, D. Mitra and G. C. Mishra, “Evidence That Glycoprotein 96 (B2), a Stress Protein, Functions as a Th2-Specific Costimulatory Molecule,” The Journal of Immunology, Vol. 169, No. 7, 2002, pp. 3507-3518. doi:10.1371/journal.pone.0007207
|
[21]
|
A. K. Mangalam, G. Rajagopalan, V. Taneja and C. S. David, “HLA Class II Transgenic Mice Mimic Human Inflammatory Diseases,” In: W. A. Frederick, Ed., Advances in Immunology, Vol. 97, Academic Press, Waltham, 2008, pp. 65-147. doi:10.1111/j.1399-0039.2012.01881.x
|
[22]
|
L. A. Baxter-Lowe and J. A. Gorsky, “Method for HLA Typing,” 1995.
http://www.google.com/patents/US5468611
|
[23]
|
M. Horlitz, A. Lucas and M. Sprenger-Haussels, “Optimized Quantification of Fragmented, Free Circulating DNA in Human Blood Plasma Using a Calibrated Duplex Real-Time PCR,” PLoS One, Vol. 4, No. 9, 2009, p. e7207.
|
[24]
|
H. Erlich, “HLA DNA Typing: Past, Present, and Future,” Tissue Antigens, Vol. 80, No. 1, 2012, pp. 1-11.
|
[25]
|
J. Holoshitz, “The Rheumatoid Arthritis HLA-DRB1 Shared Epitope,” Current Opinion in Rheumatology, Vol. 22, No. 3, 2010, pp. 293-298.
doi:10.1097/BOR.0b013e328336ba63
|
[26]
|
U. Nussinovitch and Y. Shoenfeld, “The Role of Gender and Organ Specific Autoimmunity,” Autoimmunity Reviews, Vol. 11, No. 6-7, 2012, pp. A377-A385.
doi:10.1016/j.autrev.2011.11.001
|
[27]
|
M. Behrens, M. Smart, D. Luckey, H. Luthra and V. Taneja, “To B or Not to B: Role of B Cells in Pathogenesis of Arthritis in HLA Transgenic Mice,” Journal of Autoimmunity, Vol. 37, No. 2, 2011, pp. 95-103.
doi:10.1016/j.jaut.2011.05.002
|
[28]
|
V. Taneja, M. Behrens, E. Basal, J. Sparks, M. M. Griffiths, H. Luthra and C. S. David, “Delineating the Role of the HLA-DR4 ‘Shared Epitope’ in Susceptibility versus Resistance to Develop Arthritis,” The Journal of Immunology, Vol. 181, No. 4, 2008, pp. 2869-2877.
|
[29]
|
V. Taneja, M. Behrens, A. Mangalam, M. M. Griffiths, H. S. Luthra and C. S. David, “New Humanized HLA-DR4-Transgenic Mice That Mimic the Sex Bias of Rheumatoid Arthritis,” Arthritis & Rheumatism, Vol. 56, No. 1, 2007, pp. 69-78. doi:10.1002/art.22213
|
[30]
|
S. Ling, Z. Li, O. Borschukova, L. Xiao, P. Pumpens and J. Holoshitz, “The Rheumatoid Arthritis Shared Epitope Increases Cellular Susceptibility to Oxidative Stress by Antagonizing an Adenosine-Mediated Anti-Oxidative Pathway,” Arthritis Research & Therapy, Vol. 9, No. 1, 2006, p. R5. doi:10.1186/ar2111
|
[31]
|
H. S. Ko, S. M. Fu, R. J. Winchester, D. T. Yu and H. G. Kunkel, “Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen-and antigen-activated T cells,” The Journal of Experimental Medicine, Vol. 150, No. 2, 1979, pp. 246-255. doi:10.1084/jem.150.2.246
|
[32]
|
D. T. Yu, R. J. Winchester, S. M. Fu, A. Gibofsky, H. S. Ko and H. G. Kunkel, “Peripheral blood Ia-Positive T Cells. Increases in Certain Diseases and after Immunization,” The Journal of Experimental Medicine, Vol. 151, No. 1, 1980, pp. 91-100. doi:10.1084/jem.151.1.91
|
[33]
|
A. Mangalam, M. Rodriguez and C. David, “Role of MHC Class II Expressing CD4+ T Cells in Proteolipid Protein91-110-Induced EAE in HLA-DR3 Transgenic mice,” European Journal of Immunology, Vol. 36, No. 12, 2006, pp. 3356-3370. doi:10.1002/eji.200636217
|
[34]
|
M. D. Smith and P. J. Roberts-Thomson, “Lymphocyte Surface Marker Expression in Rheumatic Diseases: Evidence for Prior Activation of Lymphocytes in Vivo,” Annals of the Rheumatic Diseases, Vol. 49, No. 2, 1990, pp. 81-87.
|
[35]
|
M. A. Zhang, D. Rego, M. Moshkova, H. Kebir, A. Chruscinski, H. Nguyen, R. Akkermann, F. Z. Stanczyk, A. Prat, L. Steinman and S. E. Dunn, “Peroxisome Proliferator-Activated Receptor (PPAR) α and -γ Regulate IFNγ and IL-17A Production by Human T Cells in a Sex-Specific Way,” Proceedings of the National Academy of Sciences, Vol. 109, No. 24, 2012, pp. 9505-9510.
doi:10.1073/pnas.1118458109
|
[36]
|
S. E. Dunn, S. S. Ousman, R. A. Sobel, L. Zuniga, S. E. Baranzini, S. Youssef, A. Crowell, J. Loh, J. Oksenberg and L. Steinman, “Peroxisome Proliferators-Activated Receptor (PPAR)α Expression in T Cells Mediates Gender Differences in Development of T Cell-Mediated Autoimmunity,” The Journal of Experimental Medicine, Vol. 204, No. 2, 2007, pp. 321-330.
doi:10.1084/jem.20061839
|
[37]
|
J. Yan, J. Greer, R. Hull, J. O’Sullivan, R. Henderson, S. Read and P. McCombe, “The Effect of Ageing on Human Lymphocyte Subsets: Comparison of Males and Females,” Immunity & Ageing, Vol. 7, No. 1, 2010, p. 4.
doi:10.1186/1742-4933-7-4
|
[38]
|
E. M. Moran, R. Heydrich, C. T. Ng, T. P. Saber, J. McCormick, J. Sieper, H. Appel, U. Fearon and D. J. Veale, “IL-17A Expression Is Localised to Both Mono-nuclear and Polymorphonuclear Synovial Cell Infiltrates,” PLoS One, Vol. 6, No. 8, 2011, Article ID: e24048.
doi:10.1371/journal.pone.0024048
|
[39]
|
A. J. Hueber, D. L. Asquith, A. M. Miller, J. Reilly, S. Kerr, J. Leipe, A. J. Melendez and I. B. McInnes, “Cutting Edge: Mast Cells Express IL-17A in Rheumatoid Arthritis Synovium,” The Journal of Immunology, Vol. 184, No. 7, 2010, pp. 3336-3340.
doi:10.4049/jimmunol.0903566
|
[40]
|
H. Appel, R. Maier, P. Wu, R. Scheer, A. Hempfing, R. Kayser, A. Thiel, A. Radbruch, C. Loddenkemper and J. Sieper, “Analysis of IL-17+ Cells in Facet Joints of Patients with Spondyloarthritis Suggests That the Innate Immune Pathway Might be of Greater Relevance than the Th17-Mediated Adaptive Immune Response,” Arthritis Research & Therapy, Vol. 13, No. 3, 2011, p. R95.
doi:10.1186/ar3370
|
[41]
|
C. Barragán-Martínez, J. Amaya-Amaya, R. Pineda-Tamayo, R. D. Mantilla, J. Castellanos-de la Hoz, S. Bernal-Macías, A. Rojas-Villarraga and J.-M. Anaya, “Gender Differences in Latin-American Patients With Rheumatoid Arthritis,” Gender Medicine, Vol. 9, No. 6, 2012, pp. 490-510.
|
[42]
|
G. Afshan, “CD4 CD25(hi) Regulatory T Cells in Healthy Males and Females Mediate Gender Difference in the Prevalence of Autoimmune Diseases,” Clinical Laboratory, Vol. 58, No. 5-6, 2012, pp. 567-571.
|
[43]
|
A. L. Feitsma, A. H. M. van der Helm-van Mil, T. W. J. Huizinga, R. R. P. de Vries and R. E. M. Toes, “Protection Against Rheumatoid Arthritis by HLA: Nature and Nurture,” Annals of the Rheumatic Diseases, Vol. 67, Suppl. 3, 2008, pp. iii61-iii63.
|
[44]
|
T. M. Holling, E. Schooten and P. J. van Den Elsen, “Function and Regulation of MHC Class II Molecules in T-Lymphocytes: Of Mice and Men,” Human Immunology, Vol. 65, No. 4, 2004, pp. 282-290.
doi:10.1016/j.humimm.2004.01.005
|
[45]
|
J.-P. Truman, M. L. Ericson, C. J. M. Choqueux-Séébold, D. J. Charron and N. A. Mooney, “Lymphocyte Programmed Cell Death Is Mediated via HLA Class II DR,” International Immunology, Vol. 6, No. 6, 1994, pp. 887-896. doi:10.1093/intimm/6.6.887
|
[46]
|
L. DiMolfetto, H. A. Neal, A. Wu, C. Reilly and D. Lo, “The Density of the Class II MHC T Cell Receptor Ligand Influences IFN-γ/IL-4 Ratios in Immune Responses in Vivo,” Cellular Immunology, Vol. 183, No. 1, 1998, pp. 70-79. doi:10.1006/cimm.1997.1231
|
[47]
|
S. Hussain and S. A. Stohlman, “Peritoneal Macrophage from Male and Female SJL Mice Differ in IL-10 Expression and Macrophage Maturation,” Journal of Leukocyte Biology, Vol. 91, No. 4, 2012, pp. 571-579.
doi:10.1189/jlb.0711351
|
[48]
|
S. C. Wilcoxen, E. Kirkman, K. C. Dowdell and S. A. Stohlman, “Gender-Dependent IL-12 Secretion by APC Is Regulated by IL-10,” The Journal of Immunology, Vol. 164, No. 12, 2000, pp. 6237-6243.
|
[49]
|
C. A. Hunter and R. Kastelein, “Interleukin-27: Balancing Protective and Pathological Immunity,” Immunity, Vol. 37, No. 6, 2012, pp. 960-969.
doi:10.1016/j.immuni.2012.11.003
|
[50]
|
H. G. Evans, T. Suddason, I. Jackson, L. S. Taams and G. M. Lord, “Optimal Induction of T Helper 17 Cells in Humans Requires T Cell Receptor Ligation in the Context of Toll-Like Receptor-Activated Monocytes,” Proceedings of the National Academy of Sciences, Vol. 104, No. 43, 2007, pp. 17034-17039. doi;10.1073/pnas.0708426104
|